<?xml version="1.0" encoding="UTF-8"?>
<p>We identified 15 antibiotics for which there had been a referral procedure during the study period 2007 to 2020, representing seven classes of antibiotics (
 <xref rid="t1" ref-type="table">Table 1</xref>, 
 <ext-link ext-link-type="uri" xlink:href="/content/10.2807/1560-7917.ES.2020.25.45.2000035#supplementary_data" xmlns:xlink="http://www.w3.org/1999/xlink">Supplementary table S1</ext-link>). Four referrals related to cephalosporins, three to penicillins, two each to fluoroquinolones, carbapenems and glycopeptide and one each to polymyxins and other antibacterial medicines. Most of the regulatory actions (n = 12) were Article 30 Directive 2001/83/EC and only three were Article 31 of Directive 2001/83/EC. Only four referral procedures were triggered by a Member State (France, Germany, the Netherlands and Spain), others (n = 11) were initiated by the EC.
</p>
